Inverse VIX Short-Term Futures ETNs due March 22, 2045 (NY:VYLD)
28.10
+0.14
(+0.49%)
Streaming Delayed Price
Updated: 11:53 AM EST, Feb 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 714 |
| Open | 28.13 |
| Bid (Size) | 28.01 (100) |
| Ask (Size) | 28.09 (100) |
| Prev. Close | 27.96 |
| Today's Range | 28.10 - 28.13 |
| 52wk Range | 14.30 - 29.68 |
| Shares Outstanding | 40,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
Frequently Asked Questions
Is Inverse VIX Short-Term Futures ETNs due March 22, 2045 publicly traded?
Yes, Inverse VIX Short-Term Futures ETNs due March 22, 2045 is publicly traded.
What exchange does Inverse VIX Short-Term Futures ETNs due March 22, 2045 trade on?
Inverse VIX Short-Term Futures ETNs due March 22, 2045 trades on the New York Stock Exchange
What is the ticker symbol for Inverse VIX Short-Term Futures ETNs due March 22, 2045?
The ticker symbol for Inverse VIX Short-Term Futures ETNs due March 22, 2045 is VYLD on the New York Stock Exchange
What is the current price of Inverse VIX Short-Term Futures ETNs due March 22, 2045?
The current price of Inverse VIX Short-Term Futures ETNs due March 22, 2045 is 28.10
When was Inverse VIX Short-Term Futures ETNs due March 22, 2045 last traded?
The last trade of Inverse VIX Short-Term Futures ETNs due March 22, 2045 was at 02/13/26 11:53 AM ET
What is the market capitalization of Inverse VIX Short-Term Futures ETNs due March 22, 2045?
The market capitalization of Inverse VIX Short-Term Futures ETNs due March 22, 2045 is 1.12M
How many shares of Inverse VIX Short-Term Futures ETNs due March 22, 2045 are outstanding?
Inverse VIX Short-Term Futures ETNs due March 22, 2045 has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.